HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vascular endothelial growth factor up-regulation via p21-activated kinase-1 signaling regulates heregulin-beta1-mediated angiogenesis.

Abstract
Heregulin-beta1 promotes the activation of p21-activated kinase 1 (Pak1) and the motility and invasiveness of breast cancer cells. In this study, we identified vascular endothelial growth factor (VEGF) as a gene product induced by heregulin-beta1. The stimulation by heregulin-beta1 of breast cancer epithelial cells induced the expression of the VEGF mRNA and protein and its promoter activity. Heregulin-beta1 also stimulated angiogenesis in a VEGF-dependent manner. Herceptin, an anti-HER2 antibody inhibited heregulin-beta1-mediated stimulation of both VEGF expression in epithelial cells and angiogenesis in endothelial cells. Because the activation of Pak1 and VEGF expression are positively regulated by heregulin-beta1, we hypothesized that Pak1 regulates VEGF expression, and hence explored the role of Pak1 in angiogenesis. We provide new evidence to implicate Pak1 signaling in VEGF expression. Overexpression of a kinase-dead K299R Pak1 leads to suppression of VEGF promoter activity, as well as VEGF mRNA expression and secretion of VEGF protein. Conversely, kinase-active T423E Pak1 promotes the expression and secretion of VEGF. Furthermore, expression of the heregulin-beta1 transgene, HRG, in harderian tumors in mice enhances the activation of Pak1 as well as expression of VEGF and angiogenic marker CD34 antigen. These results suggest that heregulin-beta1 regulates angiogenesis via up-regulation of VEGF expression and that Pak1 plays an important role in controlling VEGF expression and, consequently, VEGF secretion and function.
AuthorsR Bagheri-Yarmand, R K Vadlamudi, R A Wang, J Mendelsohn, R Kumar
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 275 Issue 50 Pg. 39451-7 (Dec 15 2000) ISSN: 0021-9258 [Print] United States
PMID10967114 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antigens, CD34
  • Drug Combinations
  • Endothelial Growth Factors
  • Laminin
  • Lymphokines
  • Neuregulin-1
  • Proteoglycans
  • RNA, Messenger
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • matrigel
  • heregulin beta1
  • Collagen
  • Phosphotransferases
  • PAK1 protein, human
  • Pak1 protein, mouse
  • Protein Serine-Threonine Kinases
  • p21-Activated Kinases
Topics
  • 3T3 Cells
  • Animals
  • Antigens, CD34 (metabolism)
  • Blotting, Northern
  • Breast Neoplasms (metabolism)
  • Cell Movement
  • Collagen (metabolism)
  • Drug Combinations
  • Endothelial Growth Factors (genetics, metabolism)
  • Genes, Dominant
  • Genes, Reporter
  • Humans
  • Laminin (metabolism)
  • Lymphokines (genetics, metabolism)
  • Mice
  • Mice, Transgenic
  • Mutagenesis
  • Neovascularization, Physiologic
  • Neuregulin-1 (metabolism)
  • Phosphotransferases (metabolism)
  • Precipitin Tests
  • Promoter Regions, Genetic
  • Protein Serine-Threonine Kinases (metabolism)
  • Proteoglycans (metabolism)
  • RNA, Messenger (metabolism)
  • Signal Transduction
  • Transgenes
  • Tumor Cells, Cultured
  • Up-Regulation
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • p21-Activated Kinases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: